Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Cefodizime Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 86329-79-5, Cefodizime disodium, Cefodizime disodium salt, Thr-221, Cefodizime sodium [jan], Hr 221
    Molecular Formula
    C20H18N6Na2O7S4
    Molecular Weight
    628.6  g/mol
    InChI Key
    WBOBLQIRACJNPA-AEKYOGSZSA-L
    FDA UNII
    HC1T51593A
    Cefodizime Sodium is the sodium salt form of cefodizime, a third-generation, aminothiazolyl cephalosporin for parenteral use. Cefodizime has broad-spectrum activity and is stable to most beta-lactamases.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    disodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxylatomethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
    2.1.2 InChI
    InChI=1S/C20H20N6O7S4.2Na/c1-7-10(3-11(27)28)37-20(22-7)36-5-8-4-34-17-13(16(30)26(17)14(8)18(31)32)24-15(29)12(25-33-2)9-6-35-19(21)23-9;;/h6,13,17H,3-5H2,1-2H3,(H2,21,23)(H,24,29)(H,27,28)(H,31,32);;/q;2*+1/p-2/b25-12-;;/t13-,17-;;/m1../s1
    2.1.3 InChI Key
    WBOBLQIRACJNPA-AEKYOGSZSA-L
    2.1.4 Canonical SMILES
    CC1=C(SC(=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-])CC(=O)[O-].[Na+].[Na+]
    2.1.5 Isomeric SMILES
    CC1=C(SC(=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-])CC(=O)[O-].[Na+].[Na+]
    2.2 Other Identifiers
    2.2.1 UNII
    HC1T51593A
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Cefodizime

    2. Cefodizime Disodium

    3. Cefodizime, Dipotassium Salt, (6r-(6alpha,7beta(z)))-isomer

    4. Cefodizime, Disodium Salt, (6r-(6alpha,7beta(z)))-isomer

    5. Hr 221

    6. Hr-221

    7. Modivid

    2.3.2 Depositor-Supplied Synonyms

    1. 86329-79-5

    2. Cefodizime Disodium

    3. Cefodizime Disodium Salt

    4. Thr-221

    5. Cefodizime Sodium [jan]

    6. Hr 221

    7. S 77 1221 B

    8. Hc1t51593a

    9. Thr 221

    10. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-, Disodium Salt, (6r,7r)-

    11. Neucef (tn)

    12. S 77-1221b

    13. S-77-1221b

    14. S-77-1221-b

    15. Unii-hc1t51593a

    16. Kenicef (tn)

    17. Ncgc00167581-01

    18. Cefodizime Sodium (jp17)

    19. Dsstox_cid_26730

    20. Dsstox_rid_81860

    21. Dsstox_gsid_46730

    22. Schembl1649045

    23. Chembl3189077

    24. Dtxsid9046730

    25. Chebi:31372

    26. Cefodizime Sodium [mart.]

    27. Tox21_112573

    28. Cefodizime Disodium [who-dd]

    29. Mfcd00897059

    30. Cefodizime Disodium Salt [mi]

    31. Akos025311226

    32. As-82212

    33. Cas-86329-79-5

    34. D01863

    35. (z)-7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-(5-carboxymethyl-4-methylthiazol-2-ylthiomethyl)-3-cephem-4-carboxylic Acid, Disodium Salt

    36. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-, Disodium Salt, (6r-(6-alpha,7-beta(z)))-

    37. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-, Disodium Salt, (6r-(6.alpha.,7.beta.(z)))-

    38. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-, Sodium Salt (1:2), (6r,7r)-

    39. Sodium (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((5-(carboxylatomethyl)-4-methylthiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 628.6 g/mol
    Molecular Formula C20H18N6Na2O7S4
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count15
    Rotatable Bond Count8
    Exact Mass627.99152019 g/mol
    Monoisotopic Mass627.99152019 g/mol
    Topological Polar Surface Area310 Ų
    Heavy Atom Count39
    Formal Charge0
    Complexity1020
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Bacterial Agents

    Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)